Wong et al. [12] developed centrinone B, a selective Plk4 inhibitor and found that centrinone-induced centrosome loss irreversibly arrested normal cells in a senescence-like G1 state by a p53-dependent mechanism whereas p53-mutant cancer cells could proliferate indefinitely after centrosome loss. Here, PLK4 is linked to cancer.